Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/02/2011EP1966208B1 (1-AZA-BICYCLO[3.3.1]NON-4-YL)-[5-(1H-INDOL-5-YL)-HETEROARYL]-AMINES AS CHOLINERGIC LIGANDS OF THE N-AChR FOR THE TREATMENT OF PSYCHOTIC AND NEURODEGENERATIVE DISORDERS
11/02/2011EP1965800B1 Piperidine derivatives for use to treat incontinences
11/02/2011EP1960387B1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
11/02/2011EP1924585B1 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
11/02/2011EP1898712B1 Fortified cereal bran to promote digestive health
11/02/2011EP1890710B1 Production of glucosamine from plant species
11/02/2011EP1853250B1 Combinations and modes of administration of therapeutic agents and combination therapy
11/02/2011EP1838674B9 Heteroaryl sulfonamides and ccr2
11/02/2011EP1827437B1 Combinations of therapeutic agents for treating cancer
11/02/2011EP1818334B1 Anti-trypanosomiasis agent
11/02/2011EP1802316B1 Purine derivatives and methods of use thereof
11/02/2011EP1802303B1 Compounds, compositions and methods of inhibiting a-synuclein toxicity
11/02/2011EP1758883B1 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
11/02/2011EP1734971B1 Polymer-based sustained release device
11/02/2011EP1732901B1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
11/02/2011EP1730110B9 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/02/2011EP1667682B1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/02/2011EP1663216B1 Modified release compositions comprising tacrolimus
11/02/2011EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011EP1535913B1 Novel quaternary ammonium compounds
11/02/2011EP1508043B1 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl
11/02/2011EP1461449B1 System for monitoring bacterial tumor treatment
11/02/2011EP1417960B1 Sustained release micropellets and process for producing the same
11/02/2011EP1399416B1 Peptide deformylase inhibitors
11/02/2011EP1339412B1 Formulation containing phosphate derivatives of electron transfer agents
11/02/2011EP1212359B1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
11/02/2011EP1100512B1 Use of thioarabinofuranosyl compounds
11/02/2011CN1989947B Process for the manufacture of particles containing antibotics and their application
11/02/2011CN1981752B Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
11/02/2011CN1946401B Alkaloid formulations
11/02/2011CN1845745B Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
11/02/2011CN1572298B Arbidol containing compound preparation
11/02/2011CN102232115A Methods and compositions for diagnosing and treating a colorectal adenocarcinoma
11/02/2011CN102232078A 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
11/02/2011CN102232076A Pyrrolopyrazinyl urea kinase inhibitors
11/02/2011CN102232075A Amino pyrazole compound
11/02/2011CN102232074A Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
11/02/2011CN102232073A New compounds I
11/02/2011CN102232072A (R)-3-(E)-2-(pyrr0lidin-3-yl) vinyl)-5-(tetrahydr0pyran-4-yl0xy) pyridine, its salts, its synthesis and its use as ligand for nicotinic acetylcholinergic receptors
11/02/2011CN102232071A Fused multicyclic compounds as protein kinase inhibitors
11/02/2011CN102232070A Synthesis and novel salt forms of (R)-5-((E)-2-(pyrrolidin-3-ylvinyl)pyrimidine
11/02/2011CN102231986A Use of phytoecdysones in the preparation of a composition for acting on metabolic syndrome
11/02/2011CN102231985A Composition for preventing adhesion
11/02/2011CN102231984A Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors
11/02/2011CN102231983A Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors
11/02/2011CN102231982A Method and composition for use in the treatment or prevention of diabetes
11/02/2011CN102231980A Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
11/02/2011CN102231978A A composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
11/02/2011CN102231948A Preservative system for emulsion-based therapeutic topical formulations
11/02/2011CN102229877A Brewing method for pine pollen wine
11/02/2011CN102229640A Application of triterpenoid saponins compound extracted from anemone taipaiensis
11/02/2011CN102229636A New derivatives of berberine coupled with cholic acid at ninth position through ester bond and preparation methods thereof
11/02/2011CN102229634A Levo-isovaleryl spiramycin I and preparation, preparation method and application thereof
11/02/2011CN102229616A Tetrahydrothieno pyridine derivative, and preparation method and purpose thereof
11/02/2011CN102229611A 2,6-diaryl pyrazolo[1,5-a]pyrazine-4(5H)-ketone compound and its application
11/02/2011CN102229609A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
11/02/2011CN102229606A 2-methylbenzofuran derivative containing isoxazole heterocycle, and preparation method and application thereof
11/02/2011CN102229605A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/02/2011CN102229603A Triazole heterocycle-containing 2-methyl benzofuran compound, and preparation and application thereof
11/02/2011CN102229602A Tacrine heterocomplex, preparation method and use in medicines for curing neurodegenerative diseases thereof
11/02/2011CN102229601A Hexahydro-1-(5-isoquinoline sulfonyl)-1 (H)-1, 4- diazepine hydrochloride amorphous compound
11/02/2011CN102229598A Mapping-agathis dammara type diterpene compound, and preparation method and application thereof
11/02/2011CN102229595A Sesquiterpenoids in Cordyceps Ophioglossoides and use thereof
11/02/2011CN102229589A N-{4'-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors
11/02/2011CN102229588A Briarane type diterpenoid compounds with anti-tumor and antibacterial activities and application thereof
11/02/2011CN102229585A [Gamma]-butyrolactone polyketone compounds with antitumor activities
11/02/2011CN102229580A Novel pleuromutilin derivate, preparation method and medical use thereof
11/02/2011CN102229574A 3-benzotriazole-substituted-1-(1,3-diaryl) propylene compound, synthesis method and use thereof
11/02/2011CN102229566A Structure of drug for treating neurodegenerative disease
11/02/2011CN102229564A 4-(7-chlorine-4aminoquinoline)-5,6,7,8-tetrahydro-alpha-naphthol derivatives, preparation method and application thereof
11/02/2011CN102229563A 4-amino quinoline derivative, preparation method and application thereof
11/02/2011CN102229562A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
11/02/2011CN102229558A New silodosin crystal form delta, preparation method thereof and pharmaceutical composition containing the same
11/02/2011CN102229557A Semihydrate crystal of silodosin, preparation method thereof and medicinal composition containing semihydrate crystal
11/02/2011CN102229547A Naphthyl phenyl ether benzenesulfonamide derivative and preparation method and purpose thereof
11/02/2011CN102229546A 1,4-pentadiene-3-ketone compound including sulfonic acid ester group, preparation method and use thereof
11/02/2011CN102229528A Method for extracting unsaturated fatty acid composition from humen amniotic epithelial cells, and application thereof
11/02/2011CN102228697A Application of microRNA (Ribonucleic Acid)-26 in preparing medicament for preventing and treating atrial fibrillation
11/02/2011CN102228696A Polyethylene glycol-polyvinyl alcohol copolymer-metaxalone prodrug and synthesis method thereof
11/02/2011CN102228691A Aspirin and anticoagulant pharmaceutical composition
11/02/2011CN102228689A In vitro cancer therapy compound identification method
11/02/2011CN102228682A Medicinal composition for treating increased blood viscosity and blood supply insufficiency of brain tissues
11/02/2011CN102228681A Fish spawning inducer and spawning induction method
11/02/2011CN102228676A Heparolysate injection pharmaceutical composition
11/02/2011CN102228669A Traditional Chinese medicine preparation for treating alopecia and preparation method thereof
11/02/2011CN102228667A External medicinal plaster for treating facial paralysis and preparation method thereof
11/02/2011CN102228650A External massage ointment for treating cervical spondylosis as well as preparation method and application thereof
11/02/2011CN102228635A Wuhuang ointment for treating burn and scald
11/02/2011CN102228622A Traditional Chinese medicine liniment for treating burn and scald
11/02/2011CN102228614A Formula and method for preparing traditional Chinese medicine for treating heart meridian tissue disease
11/02/2011CN102228597A Medicament for treating oral ulcer and preparation method
11/02/2011CN102228588A Traditional Chinese medicine composition for external use for treating sciatica, and preparation method thereof
11/02/2011CN102228586A Ointment for promoting union of bone fractures and preparation method thereof
11/02/2011CN102228575A Medicament for external use for treating hypertension, and production method thereof
11/02/2011CN102228571A Drug for treating wart
11/02/2011CN102228562A Health-care wine for preventing and treating stomach diseases
11/02/2011CN102228559A Externally applied ointment for treating children eczema
11/02/2011CN102228558A Externally-used Chinese herbal composition for treating epidemic parotitis
11/02/2011CN102228557A Chinese herbal medicine for treating paranasal sinusitis
11/02/2011CN102228555A Medicinal liquid for treating burns and scalds